Jak/Stat-mediated prolactin signal transduction culminates in the sequence-selective binding of Stat5a. However, in the absence of Stat-binding sites, a RUSH-binding element mediates the prolactin signal in the rabbit uteroglobin promoter. Speculation about the existence of a Jak/RUSH pathway prompted this series of experiments to examine potential interactions between RUSH and Stat5a. Profiles of Jak/Stat pathway-specific genes by RT-PCR showed that mRNA for Jak2 and Stat5a is expressed in the endometrium of estrous, progesterone-treated, and 5-day pseudopregnant rabbits. Interspecies microarrays showed that transcripts for Stat5a were present at equal concentrations in the endometrium regardless of hormone treatment. The absence of a physical interaction between RUSH and individual Stat proteins bound to enhancer sites was demonstrated with transcription factor interaction arrays. These studies confirm that transmission of the prolactin signal through RUSH occurs in the absence of a physical association with Stat5a. Although a strong physical interaction between RUSH and Egr-1 was identified with the same arrays, no Egr-1 consensus sites were found in the region of the uteroglobin promoter (Ϫ175/Ϫ80) that contains the authentic RUSH site. Because the major transducer molecules (Jak2, Stat5a) are activated by tyrosine phosphorylation, Western analysis of immunoprecipitated samples, and gel shift assays were used to show that tyrosine phosphorylation is required for RUSH-DNA binding. The precise role for Jak2 in this process remains undefined. By comparison, serine-threonine-specific protein phosphorylation had no effect on RUSH-DNA binding.
INTRODUCTION
Canonical prolactin signal transduction begins with hormone-receptor binding, which invokes receptor dimerization and Janus kinase 2 (Jak2) activation. Jak2 tyrosine kinases transphosphorylate themselves, the prolactin receptor, and the receptor-associated signal transducer and activator of transcription (Stat) 5a proteins. Phosphorylated Stat5a proteins dimerize and translocate to the nucleus, where they bind to DNA in a sequence-selective manner [1, 2] . Stat5a is considered to be an important mediator of prolactin ac- tion in the mammary gland [3] because Stat5a-deficient mice fail to lactate.
In the rabbit uterus, prolactin augments the progesteronedependent increase in uteroglobin mRNA [4] . The search for responsible transcription factors [5] culminated in the cloning and characterization of RUSH [6] . The acronym identified two alternatively spliced rabbit uteroglobin promoter-binding proteins, RUSH-1␣ and ␤, as SWI/SNF-related helicases/ATPases. Symbols that were later adopted for the human (SMARCA3), and mouse (Smarca3) orthologs, identified some of the same characteristics as the RUSH acronym: SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 3. When the human nomenclature is applied to the rabbit ortholog, the gene name is rabbit SMARCA3, and RUSH is retained as the trivial name.
RUSH is the only SMARCA3-related gene known to be regulated by steroids. Northern analysis showed that progesterone treatment increased the uterine content of RUSH message. Competitive reverse transcriptase-polymerase chain reaction (RT-PCR) and ion-pair reversed-phase HPLC analysis confirmed a steroid-dependent alternative splicing mechanism [6] in which RUSH-1␣ is the progesterone-dependent splice variant and RUSH-1␤ is the estrogen-dependent splice variant. Interrogation of the proximal promoter of the RUSH gene revealed a progesterone-responsive region that harbors an overlapping progesterone receptor half-site (PRE) and a nuclear factor Y (NF-Y) consensus site [7] .
RUSH then is a progesterone-regulated, SWI/SNF-related transcription factor that binds to the proximal promoter of the uteroglobin gene. The target search was initially reduced from Ϫ170/Ϫ85 to Ϫ160/Ϫ110 [8] . Although this region was large and complex, the absence of Stat5a binding elements was compelling evidence that the prolactin receptor activated a different intracellular transducer. Cyclic amplification and selection of targets was used to identify the RUSH binding site (Ϫ126/Ϫ121), and chromatin immunoprecipitation confirmed site-specific binding of RUSH to the transcriptionally active promoter [9] . Transient transfection assays with mutant constructs showed that the RUSH-binding site mediated the ability of prolactin to augment progesterone-dependent transcriptional activation of the gene [9] . The demonstration that RUSH is a prolactin signal transducer and speculation about the existence of a Jak/RUSH pathway prompted this series of experiments to examine potential interactions between RUSH and Stat5a.
MATERIALS AND METHODS

Reagents and Tools
TriReagent was purchased from Molecular Research Center Inc. (Cincinnati, OH). Human chorionic gonadotrophin (hCG), agarose-conjugated alkaline phosphatase, and sodium orthovanadate were purchased from Sigma Chemical Company (St. Louis, MO). Protein tyrosine phosphatase (PTPase), the catalytic subunit of protein phosphatase 1 (PP1), and okadaic acid were purchased from Roche Applied Sciences (Indianapolis, IN) Affinity-purified RUSH-1␣(␤) [6] and RUSH-1␣ [9] antipeptide antibodies have been extensively characterized. For immunoprecipitation, pooled aliquots of these antibodies (600 l) were dialyzed against two changes ϫ 1 L each of TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) at 4ЊC. The final concentration of the antibody was 1 mg/ml.
Animal Treatments
All studies were conducted according to the NIH Guidelines for the Care and Use of Laboratory Animals, as reviewed and approved by the Animal Care and Use Committee at Texas Tech University Health Sciences Center. Adult female New Zealand white rabbits (6 mo of age) were housed for 3 wk before experimentation.
For RNA isolation, eight rabbits were divided into two groups. One group of animals (n ϭ 3) was used as estrous controls. The second group of animals (n ϭ 3) was made pseudopregnant (PSP) by intravenous injection of 15-20 IU hCG and cervical stimulation. These PSP rabbits were killed 5 days after treatment, and ovulation was confirmed by the presence of corpora lutea at necropsy. The third group of animals was treated with progesterone (3 mg/kg/24 h) for 4 days and killed 24 h after the last injection. Ethanol:corn oil (50:50) was used as the vehicle. For nuclear extract preparations, one estrous rabbit was treated with progesterone for 5 days and killed 24 h after the last injection.
RNA Isolation
Total RNA was isolated from the endometrium of the two progesterone-treated rabbits by the cold precipitation method of Han et al. [10] . Total RNA was isolated from the endometrium of the estrous and PSP rabbits with TriReagent according to the manufacturer's instructions. The integrity of each RNA sample was confirmed by electrophoretic fractionation through formaldehyde-containing agarose gels (1.2%) and ethidium bromide staining. Poly(A ϩ )RNA was isolated with the NucleoTrap Acid Purification Kit. RNA concentrations were determined spectrophotometrically (A 260 ). The A 260/280 ratio for each sample was Ͼ1.8.
Kits and Previously Described Assays
To profile members of the JAK/STAT pathway, cDNA templates were prepared from poly(A ϩ )mRNA with the ReactionReady First Strand cDNA Synthesis Kit according to the manufacturer's instruction. RNA samples from three animals were pooled for use in each synthesis reaction. Resultant cDNA templates were used with the Human MultiGene-12 RT-PCR profiling kit according to the manufacturer's instructions. TransSignal TF-TF Interaction arrays were used as previously described by Hewetson and Chilton [7] . Nuclear extract proteins were prepared from the endometrium as described by Kleis-SanFrancisco et al. [5] . UG200 (Ϫ194/ϩ9) was 3Ј-end labeled on the coding strand at an XbaI site with [␣-32 P]dCTP using the Klenow fragment of DNA polymerase I to a specific activity of 1-2 ϫ 10 7 cpm/g. Binding reactions were performed as previously described [5] .
Dephosphorylation, Immunoprecipitation, and Western Analysis
In vitro dephosphorylation of nuclear extract proteins was achieved with three different enzymes and validated with specific inhibitors. Briefly, 100-g aliquots of nuclear extract proteins were treated with 1) 4 U alkaline phosphatase at 37ЊC to remove all phosphate groups, 2) 16 mU PTPase Ϯ sodium orthovanadate (250 M) at 37ЊC to selectively remove phosphate groups bound to tyrosine residues, or 3) 2 mU PPI Ϯ okadaic acid (2.5 picomoles) at 30ЊC to selectively remove phosphate groups bound to serine/threonine residues. Assay temperatures were predetermined by the manufacturer. Optimal amounts of enzyme and incubation times were determined empirically. Convenient incubations that resulted in complete dephosphorylation were conducted in a time range from 6 h to overnight.
Nuclear extracts (10 g) were incubated overnight at 4ЊC with 10-l aliquots of affinity-purified RUSH antibodies, followed by incubation for 2 h at 4ЊC with a 50% slurry of protein A-Sepharose. Immunoprecipitated proteins and molecular size standards were fractionated by SDS/PAGE on 10% minigels and transferred to nitrocellulose membranes. Membranes were processed for Western analysis. Briefly, membranes were blocked in Tris-buffered saline (150 mM NaCl, 20 mM Tris-HCl, pH 7.6) with 0.1% Tween 20 (TBST) and 2% powdered milk. Membranes were incubated overnight at 4ЊC in the same buffer containing horseradish peroxidaseconjugated rabbit antiphosphotyrosine (2 g/ml) antibodies and washed 3 ϫ 30 min in TBST. RUSH-specific phosphotyrosine signals were detected by chemiluminescence.
Gene Expression Profiling
Individual RNA samples were processed for interspecies microarray hybridization with Human Discover Chips, which profile 380 major genes from 30 functional groups. The CyScribe Post-Labeling Kit was used to generate CyDye-bound cDNA probes from amino allyl-labeled cDNAs synthesized from poly(A ϩ )RNA samples. To compare hormone effects, two fluorescent dyes, Cy3 and Cy5, were used to generate relative expression measures in directly competitive hybridization assays. For these assays, probes from an estrous animal were labeled with Cy3 (excitation wave length 532 nm; green fluorescence) and probes from a progesteronetreated animal were labeled with Cy5 (excitation wave length 633 nm; red fluorescence). To control for dye bias, probes from a prolactin ϩ progesterone-treated animal were labeled with Cy3. For dual-color microarray hybridizations (42ЊC), two probes were combined in the hybridization solution. This permitted simultaneous detection of hybridization signals and comparative analysis of gene expression levels. Microarrays were scanned and quantified with the ScanArray Express Laser confocal scanner and data were analyzed with the GeneTraffic Duo microarray analysis tools.
Transcription Factor (TF) Interaction Arrays
TransSignal TF-TF Interaction Array I was processed according to the manufacturer's instructions. Briefly, 50 g of nuclear extract protein from the progesterone-treated rabbit was incubated with biotin-labeled doublestranded oligonucleotide probes, i.e., a library of cis-elements. RUSH plus affiliated transcription factors were immunoprecipitated with a cocktail (1 g) of affinity-purified RUSH antibodies and magnetic protein G beads. For the negative control, the antibodies were replaced with normal IgG. Free cis-elements and nonspecific binding proteins were washed away. RUSH-affiliated biotin-labeled probes were eluted from the magnetic beads and hybridized to TranSignal Protein/DNA Array membranes. The genes on the array were spotted in duplicate at a specific concentration and again at a 1:10 dilution. This approach produced an interaction profile for RUSH and 54 different transcription factors, including Stat 1, 3, 4, 5, and 6.
RESULTS
Jak/Stat family members were profiled with the MultiGene-12 RT-PCR kit. As shown in Figure 1 , amplicons for Jak2 and Stat family members 3, 4, 5a, and 6 are expressed in the rabbit endometrium. Amplification reactions with human primers were robust, and individual PCR products were of the predicted sizes when estrous, progesterone-treated, and 5-day PSP animals were compared. The popular housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the RNA loading control. In the absence of contaminating genomic DNA, multiple bands for Stat5a suggested the existence of alternatively spliced products. Alternative explanations for these bands include amplification of other Stat5-related isoforms or hybridization with non-Stat5a mRNA and nonspecific amplification. Because this inner species survey was limited by the fact that rabbit Stat5a has not been cloned, the next 
FIG. 2.
Red-green overlay generated by subtracting image values from separate channels of the microarray scanner and superimposing them to form composite images. Arrays were cohybridized with test probes (progesterone-treated; red fluorescence) and reference probes (estrous; green fluorescence), corresponding to Cy5 and Cy3 emission channels, respectively, with the fluorescence signals indexed to red and green color palettes. Values from separate channels of the scanner were superimposed to create this composite of duplicate images for heat shock 90-kDa protein, ␣ (HSPCA), negative control (blank), laminin ␥1 (LAMC-1), Stat 5a, BCL2-antagonist/killer 1 (BAK1), cyclin-dependent kinase 5 (CDK5), and ribophorin I (RPN1).
step was to evaluate the expression of Stat5a with a hybridization assay.
Stat expression was evaluated with Human Discover Chips. These microarrays were made with 70-mer sense oligonucleotides for 380 genes printed in duplicate. Hybridization of full-length DNA probes across the entire length of long single-stranded targets for Stats 1, 2, 3, 4, and 5a enhanced gene specificity. Dual-probe hybridization allowed ratio analysis of experimental/control signals for each gene on each array. To compare hormone effects, two fluorescent dyes, Cy3 and Cy5, were used to generate replicate expression measures in two individual hybridization assays. Probes from an estrous animal were labeled with Cy3 (excitation wave length 532 nm; green fluorescence) and probes from a progesterone-treated animal were labeled with Cy5 (excitation wave length 633 nm; red fluorescence). Red and green channels were displayed in a single image or two-color overlay, in which changes in gene expression appeared as red or green spots against a background of yellow spots that correspond to transcripts that are present at equal concentrations in the two samples. As shown in Figure 2 , Stat5a as well as such genes as cyclindependent kinase 5 (CDK5) are constitutively expressed in the rabbit endometrium. Stats 1-4 were also constitutively expressed (data not shown). The hybridization of two additional microarrays with Cy3-labeled probes from a prolactin ϩ progesterone-treated animal and Cy5-lableled probes from a progesterone-treated animal increased the reliability of the microarray results and confirmed that Stat5a was constitutively expressed (data not shown) regardless of the hormonal milieu.
Potential physical associations between RUSH and non-RUSH proteins, especially Stat5, were evaluated with TransSignal TF-TF Interaction Arrays. Nuclear extract, the source of RUSH and putative binding partners, was incubated with a library of cis-elements. RUSH-affiliated transcription factors with their corresponding cis-elements were coimmunoprecipitated with RUSH antibodies. Cis-elements were eluted and hybridized to arrays. As shown in Figure  3 , there is no physical interaction between RUSH and Stat5. In fact, there was no physical affiliation between RUSH and any of the other Stat family members (Stats 1, 3, 4 , 5, and 6) tested (data not shown). In contrast, a strong phys- ical interaction occurred between RUSH and the nuclear phosphoprotein, early growth response protein 1 (Egr-1).
The potential requirement for RUSH proteins to be phosphorylated to bind to DNA was evaluated in gel-shift assays. Optimum conditions for the dephosphorylation of native RUSH in nuclear extracts with alkaline phosphatase, serine-threonine-specific phosphoprotein phosphatase 1 (PP1) Ϯ okadaic acid, and protein tyrosine phosphatase (PTPase) Ϯ sodium orthovanadate were determined empirically. Test and control nuclear extracts were immunoprecipitated with RUSH antibodies and immunoblotted with antiphosphotyrosine antibodies to verify treatment effects. As shown in Figure 4 , no phosphotyrosine-containing proteins were detectable after nuclear extracts are treated with either alkaline phosphatase or PTPase. Coincubation of nuclear extracts with PTPase and its inhibitor sodium orthovanadate protected against tyrosine-specific dephosphorylation. By comparison, serine-threonine-specific protein dephosphorylation with PP1 had no effect on phosphotyrosine detection. Gel-shift assays confirmed that in vitro dephosphorylation of RUSH in nuclear extracts with either alkaline phosphatase or PTPase selectively inhibited RUSH-DNA complex formation (Fig. 5) . Coincubation with the PTPase and sodium orthovanadate preserved RUSH-DNA complex formation. By comparison, serine-threonine-specific protein dephosphorylation with PP1 had little or no effect on RUSH-DNA binding.
DISCUSSION
Seven different Stat genes (Stat1-4, 5a/b, and 6) and their splice variants as well as four Jak kinases (Jak1-3 and Tyk2) are expressed in mammalian cells [11] . Collectively, they modulate molecular events in development, proliferation, cellular differentiation, apoptosis, and inflammation. A subset of these genes is required for canonical prolactin signaling, which begins with hormone-induced dimerization of the cognate receptor and autophosphorylation of tyrosines on associated Jak2 kinases. Jak2 rapidly phosphorylates tyrosine residue 694 in latent Stat5a proteins that dock with the receptor. Activated Stat5a proteins dissociate from the receptor, dimerize, migrate to the nucleus, and bind sequence-specific promoter elements [1, 2] . Because the Stat5a/b-deficient phenotype and the prolactin receptordeficient phenotype are identical, Ihle [12] concluded that all prolactin functions require Stat5a/b. However, in the ab-sence of any Stat5a/b-binding elements, a RUSH-binding site mediates the ability of prolactin to augment progesterone-dependent transcriptional activation of the uteroglobin gene [9] . The identification of RUSH as a nuclear effector of prolactin signals prompted the speculation that an alternative to the Jak/Stat signaling pathway coevolved. This hypothesis gains some credibility if all components of the putative pathways are expressed in the endometrium.
RT-PCR profiling for Jak/Stat pathway-specific genes confirmed the potential for growth factor and cytokine signaling in the endometrium. Amplicons for Jak2 and Stat family members 3, 4, 5a, and 6 were expressed regardless of the hormonal milieu. Subsequent to this survey, interspecies microarrays that were used for differential expression profiling confirmed that Stat5a is constitutively expressed. This finding is not surprising because Stat5a activation in the mammary gland requires neither transcription nor translation. In contrast, combinatorial regulation of RUSH includes robust transcriptional activation by progesterone [7] and steroid-dependent posttranscriptional processing [6] .
Although phosphorylation of a single tyrosine residue is required for Stat5a dimerization, serine phosphorylation [13] and threonine glycosylation [14] are also important for Stat5a function. Interactions between Stats and other nuclear factors are central to the integration of several signaltransduction pathways. The synergy between prolactin and glucocorticoid hormones requires the physical interaction of the glucocorticoid receptor with the N-terminus of Stat5a [15] . The p300/CBP, a putative integrator of the cross talk between nuclear receptors and AP-1, interacts with the Cterminus of Stat5a [16] . RUSH also participates in physical interactions with other proteins, including an atypical Ptype ATPase in the inner nuclear envelope [17] and the transcription factor GATA-4 [9] . However, the notion of a protein-binding interaction between Stat5a and RUSH was eliminated by the TF-TF assays. This finding would negate the necessity to determine, by some means such as in situ analysis, whether or not RUSH and Stat5a are coexpressed in the same cell type, except the possibility that Stat5a stimulates another factor, which then associates with RUSH, has not been eliminated. Clearly, the identification of a strong physical interaction between RUSH and Egr-1 prompted a reexamination of the region of the uteroglobin promoter (Ϫ175/Ϫ80) that contains the authentic RUSH site (Ϫ126/ Ϫ121). Analysis with MatInspector V2.2 [18] failed to identify any Egr-1 consensus sites. Interest in a RUSH-Egr-1 interaction was piqued by the fact that Egr-1 plays an important role in activating the LH␤ promoter [19] and, in that regard, is critical for female fertility [20] . Egr-1 has been identified in the human [21] and rodent [22] uterus, and it is known to interact physically with the tumor suppressor p53 [23] .
Seven primary mechanisms control transcription: Hedgehog, Wnt, transforming growth factor-␤, receptor tyrosine kinase, NOTCH, Jak/Stat, and nuclear receptors [24] . Although these mechanisms involve diverse pathways, they all require ligand-receptor binding and signal-related transcription factors to activate target genes. In the endometrium where Stat5a is present, prolactin activates the uteroglobin gene in the absence of Stat-binding elements. We have proffered Jak/RUSH as an alternative to the Jak/Stat pathway. The final phase of this study showed that tyrosine phosphorylation was required for RUSH-DNA binding, thus adding a further level of complexity to the molecular mechanism of RUSH action. A physical affiliation between Jak2 and RUSH was previously established by coimmunoprecipitation [9] . However, an authentic Jak/RUSH pathway is predicated on the ability of Jak2 to phosphorylate RUSH proteins. The goal of future experiments will be to directly test the hypothesis that Jak2 phosphorylates specific tyrosine residues in RUSH.
